Beyond cancer · 140+ conditions
DermaPrime's classifier doesn't only look for cancer. It recognises common inflammatory, autoimmune and benign conditions so the right ones are escalated and the rest are reassured.
Itchy inflamed patches — often confused with early lymphoma.
Affects ~10% of adults and 20% of children. Driven by skin-barrier dysfunction and Th2 inflammation. Treated with emollients, topical steroids, calcineurin inhibitors and biologics (dupilumab).
Silvery plaques on elbows/knees, autoimmune origin.
Th17-driven autoimmune disease affecting ~2–3% of the population. Associated with arthritis, cardiovascular disease and metabolic syndrome.
Central facial redness with visible vessels.
Four subtypes (erythematotelangiectatic, papulopustular, phymatous, ocular). Triggers include sun, alcohol, heat and spicy food.
Inflammatory follicular disease — most common skin condition globally.
Affects ~85% of people aged 12–24. Pathogenesis: sebum, hyperkeratinisation, C. acnes, inflammation. Severe forms need isotretinoin.
Loss of pigment patches — autoimmune melanocyte destruction.
Affects ~1% globally. Treated with topical steroids, calcineurin inhibitors, phototherapy and emerging JAK inhibitors (ruxolitinib).
Benign 'stuck-on' brown plaques — common after 40.
Completely benign but frequently mistaken for melanoma. Distinguished by their waxy, stuck-on appearance and horn cysts on dermoscopy.
Firm benign nodule, often on legs, dimples on pinch.
Reactive fibroblastic proliferation. The 'dimple sign' (central depression on lateral pinch) is pathognomonic.
Cherry angiomas, spider veins — usually benign.
Includes cherry angiomas, pyogenic granulomas, angiokeratomas and infantile hemangiomas. Most are benign; rapidly bleeding lesions warrant review.
Educational summaries only — not a substitute for a diagnosis. Always consult a qualified clinician for symptoms that worry you.
